Access Bio, Inc.
KOE: 950130.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Young-Ho Choi
- Employees
- 101
- Headquarters
- Somerset, United States
- IPO year
- 2013
- Market cap
- ₩112.9B
- Website
- https://accessbio.net
Loading 950130…
Loading profile data…Frequently asked questions about 950130
What does Access Bio, Inc. (950130.KQ) do?
Access Bio, Inc. engages in the research, development, and manufacture of in vitro rapid diagnostic tests, biosensors, and molecular diagnostic products worldwide. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2.; rapid diagnostic tests, suitable for preliminary diagnosis or...
Where does 950130.KQ trade?
Access Bio, Inc. (950130.KQ) trades on the KOSDAQ.
What sector is 950130.KQ in?
Access Bio, Inc. (950130.KQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Access Bio, Inc.?
Young-Ho Choi is the chief executive officer of Access Bio, Inc. (950130.KQ).
Where is Access Bio, Inc. headquartered?
Access Bio, Inc. is headquartered in United States.
Does 950130.KQ pay a dividend?
Yes — Access Bio, Inc. (950130.KQ) paid a trailing twelve-month dividend of KRW 871.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 950130.KQ go public?
Access Bio, Inc. (950130.KQ) completed its initial public offering in 2013.